Central Mini Ratna PSU HLL broadens population health role
Thiruvananthapuram, July 10 (IANS) Marking World Population Day, Central government PSU HLL Lifecare Ltd on Friday announced a significant expansion of its mandate, broadening its mission beyond population control to embrace the larger goal of population health, while continuing to play a pivotal role in India’s family planning programme.
The strategic shift reflects the growing emphasis of HLL, a Mini Ratna PSU under the Union Ministry of Health and Family Welfare, on preventive healthcare, affordable medical services and innovation aimed at improving the overall health and well-being of the population, particularly women and young people.
“World Population Day 2026 is a reminder that investing in people’s health, especially that of young people, is essential for building healthier and more resilient societies,” it said, adding that innovation would remain central to its mission of developing affordable, accessible and high-quality healthcare products and services.
While reaffirming its decades-long commitment to the Centre’s family planning initiatives, HLL said it has substantially expanded its healthcare portfolio to address emerging public health challenges.
The company today manufactures and supplies a comprehensive range of reproductive and maternal healthcare products, including condoms, oral contraceptive pills, emergency contraceptive pills, pregnancy detection kits, intrauterine contraceptive devices, and maternal healthcare solutions.
The PSU has also strengthened its focus on sustainable healthcare with the development of HappyDays Earth, a compostable sanitary napkin that complies with the latest BIS-2025 standards.
The product is designed to significantly reduce plastic waste and eliminate microplastic generation while ensuring safe disposal and maintaining high performance standards.
Beyond manufacturing healthcare products, HLL has considerably expanded access to affordable healthcare through its nationwide network of AMRIT Pharmacies and HINDLABS.
While AMRIT Pharmacies offer life-saving medicines, implants and medical consumables at discounts of up to 50 per cent, HINDLABS provides quality diagnostic services at prices generally 30 to 60 per cent lower than prevailing market rates, reducing healthcare costs for thousands of patients.
Building on this model, the company has further diversified into AMRIT Plus Pharmacies, Specialty HINDLABS, and HLL Home Healthcare Services.
The newer initiatives include advanced genomic and molecular diagnostic services, next-generation sequencing, skilled nursing, physiotherapy, rehabilitation, chronic disease management, elderly care, and teleconsultation, enabling quality healthcare to reach patients in their homes.
With its expanded mandate, HLL is positioning itself not merely as the government’s family planning agency but as a comprehensive public healthcare institution, aligning its future growth with India’s evolving healthcare priorities and the broader objective of ensuring healthier lives for all.
–IANS
sg/vd